No Data
No Data
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
List of stocks with buy conversion market Code Company Name Closing Price SAR Tokyo Main Board <6371> Tsubakimoto Chain 1962 1819 <6379> Raiznek 1579 1520 <6430> Daikoku Denki 3400 3280 <6472> NTN 2562 238 <6508> Meidensha 4120 3785 <6651> Nippon Kodo 3000 2868 <6653> Seiko Denki 1281 1226 <6701> NEC 13
Transgene and NEC obtained new immunological data supporting the efficacy of the personalized neoantigen cancer vaccine TG4050 for head and neck cancer.
On November 8, 2024, Transgene SA and Japan Electricity Corporation announced the data of a 24-month follow-up study of the Phase I clinical trial at the Society for Immunotherapy of Cancer (SITC 2024) in the USA. In this data, it was shown that all patients who received TG4050 as an additional treatment after standard adjuvant therapy completion for head and neck cancer maintained no recurrence. TG4050 induced a specific and sustained immune response. Currently, Phase I clinical
NEC (TSE:6701) Set for Q2 2025 Earnings Call as Digital Innovation Drives Market Expansion
NEC and NEC Bio have developed a generated AI model to predict important T-cell receptors for cancer immunotherapy, and have confirmed good results in basic validation.
On November 7, 2024, japan Electricity Ltd. and NEC Bio B.V. utilized their unique AI technology to predict T cell receptors (TCRs) highly reactive to cancer cell-derived antigens. They confirmed that the predicted TCRs expressed in T cell lines can induce stronger T cell activity. This could bring innovation to the future development of cancer immunotherapy utilizing TCRs. japan Electricity Ltd. (hereinafter NEC) and NEC's drug discovery
Nikkei Average Contribution Ranking (pre-closing) ~ Nikkei Average rose significantly, with Advantest pushing up about 155 yen by one stock.
As of the closing time six days ago, the number of rising stocks in the Nikkei average constituent stocks was 206, with 18 declining stocks and 1 unchanged stock. The Nikkei average continued to rise significantly. It closed the morning session at 39,341.44 yen, up 866.54 yen (+2.25%) from the previous day, with an estimated volume of 1,040 million shares traded. The U.S. market on the 5th day saw an increase. The Dow rose by 427.28 points to 42,221.88, and the Nasdaq rose by 259.19 points to 18,439.17 at the close of trading. Presidential election passage.
The Nikkei average started 97 yen lower, with companies such as M3 and Hitachi experiencing a decline.
[Nikkei Stock Average・TOPIX (Table)] Nikkei Average; 39179.72; -97.67 TOPIX; 2697.19; -6.53 [Morning Situation] The Nikkei Average on the 31st started trading with a decline of 97.67 yen to 39,179.72 yen, falling for the first time in 4 days. The US stock market on the previous day, the 30th, experienced a decline. Dow Jones fell by 91.51 points to 42,141.54 dollars and Nasdaq ended trading at 18,607.93, down by 104.82 points. Heavy equipment maker Caterpillar (
No Data
No Data